A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes.
Ontology highlight
ABSTRACT: The breakdown of toll-like receptor (TLR) tolerance results in tissue damage, and hyperactivation of the TLRs and subsequent inflammatory consequences have been implicated as risk factors for more severe forms of disease and poor outcomes from various diseases including COVID-19 and metabolic (dysfunction) associated fatty liver disease (MAFLD). Here we provide evidence that membrane bound O-acyltransferase domain containing 7 (MBOAT7) is a negative regulator of TLR signalling. MBOAT7 deficiency in macrophages as observed in patients with MAFLD and in COVID-19, alters membrane phospholipid composition. We demonstrate that this is associated with a redistribution of arachidonic acid toward proinflammatory eicosanoids, induction of endoplasmic reticulum stress, mitochondrial dysfunction, and
SUBMITTER: Alharthi J
PROVIDER: S-EPMC9726889 | biostudies-literature | 2022 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA